Rating Upside
SELL (■) (11.8) %
RE’s domestic volumes declined 5% yoy in Q3, led by declines in major states such as Change in Estimates
Tamil Nadu (-37%), Kerala (-24%), Gujarat (-25%), Maharashtra (-15%), Karnataka (-9%), EPS Chg FY19E/FY20E (%) -/-
and Andhra Pradesh (-11%). The number of states witnessing a decline has increased Target Price change (%) NA
to 18 in Q3 from 10 in Q2, with the addition of major states including Tamil Nadu Target Period (Months) 12
and Andhra Pradesh.
Previous Reco SELL
South region volumes declined sharply by 21%, while West region fell 7%. In comparison, Emkay vs Consensus
the North and East regions grew at a slower pace of 5% and 12%, respectively. The
EPS Estimates
company has indicated price increases and model-year change impact as the major
reasons for volume declines. As per our channel checks, volume performance was also FY19E FY20E
impacted due to the emergence of strong competition. Emkay 835.6 956.4
Vehicle prices have increased substantially (more than 15%) in the 350cc category Consensus 861.0 1,017.3
motorcycles due to an increase in insurance premiums (~3%), adoption of new safety Mean Consensus TP (12M) Rs 22,959
norms (~10%), and pass-through of commodity inflation (~2%). Prices are expected to Stock Details
increase further in Apr'20 due to the transition to BS6 emission norms (3-6%). Bloomberg Code EIM IN
Competitive intensity has increased in the cruiser motorcycles segment after the entry of Face Value (Rs) 10
Jawa Motorcycles, which has provided an alternative to RE's unique brand positioning and Shares outstanding (mn) 27
offerings. Jawa has witnessed strong order bookings, and its existing production capacity
52 Week H/L 32,237 / 18,780
is fully booked until Sep'19.
M Cap (Rs bn/USD bn) 557 / 7.80
After 3% volume growth for RE in FY19E, we expect the growth rate to remain in single
Daily Avg Volume (nos.) 122,745
digits at 9% in FY20E and 6% in FY21E. This is notably lower than the 46% volume CAGR
over FY13-18. We have assumed revenue/earnings growth of 14%/9% over FY18-21E. Daily Avg Turnover (US$ mn) 36.7
We have a Sell rating on the stock, with a target price of Rs18,000, valuing the RE
Shareholding Pattern Dec '18
business at a PE of 17x and the VECV business at a PE of 15x.
Promoters 49.3%
Substantial increase in vehicle prices: Vehicle prices have increased substantially FIIs 30.8%
(more than 15%) in the 350cc category motorcycles due to an increase in insurance DIIs 6.2%
premiums (~3%), adoption of new safety norms (~10%), and pass-through of commodity Public and Others 13.7%
inflation (~2%). Prices are expected to increase further in Apr'20 due to the transition to
BS6 emission norms (3-6%). The sharp price increases have resulted in a Price Performance
postponement of purchases and in marginal down-trading toward lower (%) 1M 3M 6M 12M
displacement vehicles as well. Absolute 1 (18) (28) (25)
Credible competition emerges: Competitive intensity has increased in the cruiser Rel. to Nifty 4 (17) (22) (26)
motorcycles segment with the launch of Jawa motorcycles by Classic Legends.
Relative price chart
Jawa/Jawa42 motorcycles have received strong order bookings and its existing production
31600 Rs % 20
capacity is fully booked until Sep’19. Another product, Jawa Perak, is expected to be
launched by the end of 2019. We expect the cruiser motorcycles segment (300-650cc) 29050 8
to see an 8% CAGR over FY18-21E, driven by strong demand for Jawa (our FY20/21 26500 -4
Please see our sector EAP (page 7): Emkay Alpha Portfolio – Automobiles & Auto 21400 -28
Ancillaries
18850 -40
Feb-18 Apr-18 Jun-18 Aug-18 Oct-18 Dec-18 Feb-19
Financial Snapshot (Consolidated) Eicher Motors (LHS) Rel to Nifty (RHS)
1,000,000 80
67
59
800,000 52 53
50 60
600,000
31 40
400,000 23
18 18
9 20
200,000
3
0 0
FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19E
Exhibit 2: Yearly state-wise growth trend – volume under pressure in West and South regions
Share Growth (%)
(%) FY15 FY16 FY17 FY18 9MFY19
Total 100 59 54 31 23 6
Zone wise
South Zone 35 63 57 39 14 (3)
North Zone 30 53 56 34 35 15
West Zone 21 63 49 14 12 (3)
East Zone 14 61 53 33 47 28
Top 10 states
Kerala 11 76 76 43 20 (5)
Tamil Nadu 10 50 63 64 20 (7)
U.P. 10 91 73 57 61 25
Maharashtra 9 64 38 3 (5) (14)
Delhi 7 63 61 33 22 8
Karnataka 7 65 45 21 (8) (10)
Punjab 6 42 36 15 21 9
Gujarat 5 73 57 28 19 (15)
Telangana 4 147 22 14
Bihar 3 104 24 36 52 41
Source: SIAM, Emkay Research
Exhibit 3: Quarterly state-wise growth trend – decline continues in South and West regions
Growth (%)
1QFY18 2QFY18 3QFY18 4QFY18 1QFY19 2QFY19 3QFY19
Total 25 22 18 28 23 3 (5)
Zone wise
South Zone 27 19 0 14 13 (2) (21)
North Zone 35 32 29 43 32 8 5
West Zone 9 6 12 20 7 (7) (7)
East Zone 33 41 60 52 55 23 12
Top 10 states
Kerala 24 26 21 8 25 (10) (24)
Tamil Nadu 43 29 (12) 29 11 1 (37)
U.P. 52 61 60 68 64 9 8
Maharashtra (3) (16) (6) 6 (15) (11) (15)
Delhi 24 17 18 30 18 4 3
Karnataka 7 (9) (22) (9) (11) (8) (9)
Punjab 22 21 13 29 5 6 15
Gujarat 24 21 16 16 6 (23) (25)
Telangana 35 28 9 20 30 11 2
Bihar 34 30 79 65 74 46 13
Source: SIAM, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
185,000 179,000
7,000
180,000
175,000 5,000
170,000 9,000
165,000
158,000
160,000
155,000
150,000
145,000
Earlier price Disc brakes cost Insurance cost ABS cost Latest price
Exhibit 6: Comparison of technical specifications between Classic 350, Jawa Forty Two, and Jawa
Classic 350 Jawa forty two Jawa
Ex-showroom Delhi 147,464 155,000 164,000
Engine capacity (cc) 346 293 293
Power (bhp) 20 27 27
Torque (Nm) 28 28 28
Front tyres (inch) 19 18 18
Rear tyres (inch) 18 17 17
Front brakes Disc Disc Disc
Rear brakes Drum Drum Drum
Kerb weight (kg) 192 170 170
Source: Company, Emkay Research
100 3 5 6 7
8 8
13 15 15
80 17 15 16
60
40 84 81 79 76 76 77
20
0
FY14 FY15 FY16 FY17 FY18 FY19 YTD
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
50
40
30
20
10
0
-10
Feb-09
Aug-12
Feb-18
Aug-09
Aug-10
Aug-11
Aug-13
Aug-14
Aug-15
Aug-16
Aug-17
Aug-18
Feb-10
Feb-11
Feb-12
Feb-13
Feb-14
Feb-15
Feb-16
Feb-17
Feb-19
1yr Fwd PE (x) Average PE +1 STD -1 STD
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Balance Sheet
Y/E Mar (Rs mn) FY17 FY18 FY19E FY20E FY21E
Equity share capital 272 273 273 273 273
Reserves & surplus 53,179 70,028 88,818 110,468 133,906
Net worth 53,451 70,301 89,090 110,741 134,178
Minority Interest 0 0 0 0 0
Loan Funds 1,119 1,508 1,553 1,717 1,869
Net deferred tax liability 778 1,421 1,730 2,087 2,484
Total Liabilities 55,347 73,230 92,373 114,545 138,532
Net block 8,686 14,978 20,080 24,547 27,319
Investment 49,913 55,847 75,847 95,847 119,847
Current Assets 7,754 21,065 16,206 17,318 18,010
Cash & bank balance 251 12,120 6,241 5,638 4,755
Other Current Assets 860 2,263 2,505 2,936 3,339
Current liabilities & Provision 14,744 21,992 23,039 26,448 29,105
Net current assets (6,990) (928) (6,834) (9,130) (11,094)
Misc. exp 0 0 0 0 0
Total Assets 55,347 73,230 92,373 114,545 138,532
Cash Flow
Y/E Mar (Rs mn) FY17 FY18 FY19E FY20E FY21E
PBT (Ex-Other income) (NI+Dep) 20,166 27,990 27,176 30,639 33,250
Other Non-Cash items 0 0 0 0 0
Chg in working cap 1,635 6,450 336 2,050 1,479
Operating Cashflow 14,806 22,022 21,813 26,102 27,030
Capital expenditure (5,470) (8,120) (8,000) (8,000) (6,000)
Free Cash Flow 9,336 13,902 13,813 18,102 21,030
Investments (12,022) (5,934) (20,000) (20,000) (24,000)
Other Investing Cash Flow 57 (7,397) 0 0 0
Investing Cashflow (15,163) (18,649) (24,065) (22,959) (23,539)
Equity Capital Raised 57 1 0 0 0
Loans Taken / (Repaid) 213 390 44 164 153
Dividend paid (incl tax) 0 (3,608) (3,843) (4,457) (4,940)
Other Financing Cash Flow (138) 11,769 234 614 483
Financing Cashflow 115 8,497 (3,628) (3,745) (4,374)
Net chg in cash (241) 11,869 (5,879) (603) (883)
Opening cash position 492 251 12,120 6,241 5,638
Closing cash position 251 12,120 6,241 5,638 4,755
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Key Ratios
Profitability (%) FY17 FY18 FY19E FY20E FY21E
EBITDA Margin 30.9 31.3 30.2 29.4 28.3
EBIT Margin 28.7 28.8 27.3 26.4 25.2
Effective Tax Rate 32.1 32.7 35.0 34.5 34.0
Net Margin 21.7 21.5 20.3 20.1 19.8
ROCE 48.6 44.6 37.4 34.6 31.4
ROE 38.1 35.2 28.6 26.1 23.2
RoIC 1,040.7 1,531.0 605.7 365.9 313.6
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
21-Feb-16
19-Aug-16
14-Aug-17
15-Feb-17
10-Feb-18
9-Aug-18
5-Feb-19
14-Nov-17 30,090 38,000 12m Accumulate Raghunandhan NL
4-Oct-17 30,885 34,000 12m Accumulate Raghunandhan NL
4-Sep-17 31,754 33,000 12m Accumulate Raghunandhan NL Source: Bloomberg, Company, Emkay Research
9-Aug-17 31,489 33,000 12m Accumulate Raghunandhan NL
13-Jul-17 28,056 28,000 12m Accumulate Kaushal Maroo
5-May-17 25,833 28,000 12m Accumulate Kaushal Maroo
3-Feb-17 23,386 27,000 12m Accumulate Kaushal Maroo
1-Feb-17 24,030 27,000 12m Accumulate Kaushal Maroo
7-Dec-16 23,382 26,000 12m Accumulate Kaushal Maroo
29-Jul-16 22,461 22,500 12m Accumulate Kaushal Maroo
6-May-16 20,216 21,200 12m Accumulate Kaushal Maroo
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
DISCLAIMERS AND DISCLOSURES: Emkay Global Financial Services Limited (CIN-L67120MH1995PLC084899) and its affiliates are a full-service, brokerage, investment banking, investment
management and financing group. Emkay Global Financial Services Limited (EGFSL) along with its affiliates are participants in virtually all securities trading markets in India. EGFSL was established in 1995
and is one of India's leading brokerage and distribution house.EGFSL is a corporate trading member of Bombay Stock Exchange Limited (BSE), National Stock Exchange of India Limited(NSE), MCX Stock
Exchange Limited (MCX-SX).EGFSL along with its subsidiaries offers the most comprehensive avenues for investments and is engaged in the businesses including stock broking (Institutional and retail),
merchant banking, commodity broking, depository participant, portfolio management, insurance broking and services rendered in connection with distribution of primary market issues and financial products
like mutual funds, fixed deposits. Details of associates are available on our website i.e. www.emkayglobal.com
EGFSL is registered as Research Analyst with SEBI bearing registration Number INH000000354 as per SEBI (Research Analysts) Regulations, 2014. EGFSL hereby declares that it has not defaulted with
any stock exchange nor its activities were suspended by any stock exchange with whom it is registered in last five years, except that NSE had disabled EGFSL from trading on October 05, October 08 and
October 09, 2012 for a manifest error resulting into a bonafide erroneous trade on October 05, 2012. However, SEBI and Stock Exchanges have conducted the routine inspection and based on their
observations have issued advice letters or levied minor penalty on EGFSL for certain operational deviations in ordinary/routine course of business. EGFSL has not been debarred from doing business by
any Stock Exchange / SEBI or any other authorities; nor has its certificate of registration been cancelled by SEBI at any point of time.
EGFSL offers research services to clients as well as prospects. The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject
company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.
Other disclosures by Emkay Global Financial Services Limited (Research Entity) and its Research Analyst under SEBI (Research Analyst) Regulations, 2014 with reference to the subject
company(s) covered in this report-:
EGFSL or its associates may have financial interest in the subject company.
Research Analyst or his/her relative’s financial interest in the subject company. (NO)
EGFSL or its associates and Research Analyst or his/her relative’s does not have any material conflict of interest in the subject company. The research Analyst or research entity (EGFSL) have not been
engaged in market making activity for the subject company.
EGFSL or its associates may have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report.
Research Analyst or his/her relatives have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research
Report: (NO)
EGFSL or its associates may have received any compensation including for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EGFSL or its
associates may have received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EGFSL or
its associates may have received any compensation or other benefits from the Subject Company or third party in connection with the research report. Subject Company may have been client of EGFSL or
its associates during twelve months preceding the date of distribution of the research report and EGFSL may have co-managed public offering of securities for the subject company in the past twelve months.
The research Analyst has served as officer, director or employee of the subject company: (NO)
The Research Analyst has received any compensation from the subject company in the past twelve months: (NO)
The Research Analyst has managed or co‐managed public offering of securities for the subject company in the past twelve months: (NO)
The Research Analyst has received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months: (NO)
The Research Analyst has received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months:
(NO)
The Research Analyst has received any compensation or other benefits from the subject company or third party in connection with the research report: (NO)
EGFSL and/or its affiliates may seek investment banking or other business from the company or companies that are the subject of this material. Our salespeople, traders, and other professionals may provide
oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make
investment decisions that may be inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give
rise to real or potential conflicts of interest including but not limited to those stated herein. Additionally, other important information regarding our relationships with the company or companies that are the
subject of this material is provided herein. This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or
other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject EGFSL or its group companies to any registration or licensing requirement
within such jurisdiction. Specifically, this document does not constitute an offer to or solicitation to any U.S. person for the purchase or sale of any financial instrument or as an official confirmation of any
transaction to any U.S. person. Unless otherwise stated, this message should not be construed as official confirmation of any transaction. No part of this document may be distributed in Canada or used by
private customers in United Kingdom. All material presented in this report, unless specifically indicated otherwise, is under copyright to Emkay. None of the material, nor its content, nor any copy of it, may
be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of EGFSL . All trademarks, service marks and logos used in this report are trademarks
or registered trademarks of EGFSL or its Group Companies. The information contained herein is not intended for publication or distribution or circulation in any manner whatsoever and any unauthorized
reading, dissemination, distribution or copying of this communication is prohibited unless otherwise expressly authorized. Pl ease ensure that you have read “Risk Disclosure Document for Capital Market
and Derivatives Segments” as prescribed by Securities and Exchange Board of India before investing in Indian Securities Market. In so far as this report includes current or historic information, it is believed
to be reliable, although its accuracy and completeness cannot be guaranteed.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. www.emkayglobal.com
ED: ANISH MATHEW SA: DHANANJAY SINHA February 19, 2019 | 8
Eicher Motors (EIM IN) India Equity Research | Company Update
Raghunandhan N L, MBA
raghunandhan.nl@emkayglobal.com
+91 22 6624 2428
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.